Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Liabilities (2016 - 2025)

Mimedx's Total Liabilities history spans 15 years, with the latest figure at $86.1 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 21.6% year-over-year to $86.1 million; the TTM value through Dec 2025 reached $86.1 million, up 21.6%, while the annual FY2025 figure was $86.1 million, 21.6% up from the prior year.
  • Total Liabilities for Q4 2025 was $86.1 million at Mimedx, up from $80.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $194.3 million in Q2 2021 and bottomed at -$1.3 million in Q3 2023.
  • The 5-year median for Total Liabilities is $77.3 million (2025), against an average of $82.8 million.
  • The largest annual shift saw Total Liabilities crashed 106.81% in 2023 before it skyrocketed 4828.05% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $95.4 million in 2021, then grew by 1.65% to $96.9 million in 2022, then fell by 0.61% to $96.3 million in 2023, then decreased by 26.49% to $70.8 million in 2024, then increased by 21.6% to $86.1 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Total Liabilities are $86.1 million (Q4 2025), $80.0 million (Q3 2025), and $74.5 million (Q2 2025).